OBJECTIVE: We assessed the association between early increases in albumin excretion and cardiovascular (CV) and renal markers in a large cohort of young people with type 1 diabetes. RESEARCH DESIGN AND METHODS: As part of preliminary screening for a multicenter, randomized controlled trial of statins/ACE inhibitors, we measured albumin-creatinine ratio (ACR) in six early morning urine samples from 3,353 adolescents (10-16 years of age) and calculated tertiles based on an established algorithm. From those subjects deemed to be at higher risk (upper ACR tertile), we recruited 400 into the intervention study (trial cohort). From those subjects deemed to be at lower risk (middle-lower ACR tertiles), we recruited 329 to the observation cohort. At baseline, vascular measurements (carotid intima-media thickness, pulse wave velocity [PWV], flow-mediated dilatation, digital pulse amplitude tonometry), renal markers (symmetric dimethylarginine, cystatin C, creatinine), and CV disease markers (lipids and apolipoproteins [Apo] A-1 and B, C-reactive protein, asymmetric dimethylarginine) were assessed. RESULTS: Age- and sex-adjusted PWV was higher in the trial than in the observational cohort (5.00 ± 0.84 vs. 4.86 ± 0.70 m/s; P = 0.021). Similarly, non-HDL cholesterol (2.95 ± 0.83 vs. 2.81 ± 0.78 mmol/L; P = 0.02) and ApoB-ApoA-1 ratio (0.50 ± 0.14 vs. 0.47 ± 0.11; P = 0.04) were higher in the trial cohort. Cystatin C and creatinine were decreased (0.88 ± 0.13 vs. 0.90 ± 0.13 mg/L, P = 0.04; 51.81 ± 10.45 vs. 55.35 ± 11.05 μmol/L, P < 0.001; respectively) and estimated glomerular filtration rate (137.05 ± 23.89 vs. 129.31 ± 22.41 mL/min/1.73 m(2); P < 0.001) increased in the trial compared with the observational cohort. CONCLUSIONS: Our data demonstrate that in adolescents with type 1 diabetes, the group with the highest tertile of albumin excretion showed more evidence of early renal and CV disease than those in the lower tertiles.
OBJECTIVE: We assessed the association between early increases in albumin excretion and cardiovascular (CV) and renal markers in a large cohort of young people with type 1 diabetes. RESEARCH DESIGN AND METHODS: As part of preliminary screening for a multicenter, randomized controlled trial of statins/ACE inhibitors, we measured albumin-creatinine ratio (ACR) in six early morning urine samples from 3,353 adolescents (10-16 years of age) and calculated tertiles based on an established algorithm. From those subjects deemed to be at higher risk (upper ACR tertile), we recruited 400 into the intervention study (trial cohort). From those subjects deemed to be at lower risk (middle-lower ACR tertiles), we recruited 329 to the observation cohort. At baseline, vascular measurements (carotid intima-media thickness, pulse wave velocity [PWV], flow-mediated dilatation, digital pulse amplitude tonometry), renal markers (symmetric dimethylarginine, cystatin C, creatinine), and CV disease markers (lipids and apolipoproteins [Apo] A-1 and B, C-reactive protein, asymmetric dimethylarginine) were assessed. RESULTS: Age- and sex-adjusted PWV was higher in the trial than in the observational cohort (5.00 ± 0.84 vs. 4.86 ± 0.70 m/s; P = 0.021). Similarly, non-HDL cholesterol (2.95 ± 0.83 vs. 2.81 ± 0.78 mmol/L; P = 0.02) and ApoB-ApoA-1 ratio (0.50 ± 0.14 vs. 0.47 ± 0.11; P = 0.04) were higher in the trial cohort. Cystatin C and creatinine were decreased (0.88 ± 0.13 vs. 0.90 ± 0.13 mg/L, P = 0.04; 51.81 ± 10.45 vs. 55.35 ± 11.05 μmol/L, P < 0.001; respectively) and estimated glomerular filtration rate (137.05 ± 23.89 vs. 129.31 ± 22.41 mL/min/1.73 m(2); P < 0.001) increased in the trial compared with the observational cohort. CONCLUSIONS: Our data demonstrate that in adolescents with type 1 diabetes, the group with the highest tertile of albumin excretion showed more evidence of early renal and CV disease than those in the lower tertiles.
Authors: Petter Bjornstad; Laura Pyle; Nhung Nguyen; Janet K Snell-Bergeon; Franziska K Bishop; R Paul Wadwa; David M Maahs Journal: Pediatr Diabetes Date: 2015-02 Impact factor: 4.866
Authors: Julie A Lovshin; Marko Škrtić; Petter Bjornstad; Rahim Moineddin; Denis Daneman; David Dunger; Heather N Reich; Farid Mahmud; James Scholey; David Z I Cherney; Etienne Sochett Journal: Am J Physiol Renal Physiol Date: 2017-12-13
Authors: Katherine R Tuttle; George L Bakris; Rudolf W Bilous; Jane L Chiang; Ian H de Boer; Jordi Goldstein-Fuchs; Irl B Hirsch; Kamyar Kalantar-Zadeh; Andrew S Narva; Sankar D Navaneethan; Joshua J Neumiller; Uptal D Patel; Robert E Ratner; Adam T Whaley-Connell; Mark E Molitch Journal: Diabetes Care Date: 2014-10 Impact factor: 19.112
Authors: Timothy J Bradley; Cameron Slorach; Farid H Mahmud; David B Dunger; John Deanfield; Livia Deda; Yesmino Elia; Ronnie L H Har; Wei Hui; Rahim Moineddin; Heather N Reich; James W Scholey; Luc Mertens; Etienne Sochett; David Z I Cherney Journal: Cardiovasc Diabetol Date: 2016-02-16 Impact factor: 9.951
Authors: Adeera Levin; Evan Adams; Brendan J Barrett; Heather Beanlands; Kevin D Burns; Helen Hoi-Lun Chiu; Kate Chong; Allison Dart; Jack Ferera; Nicolas Fernandez; Elisabeth Fowler; Amit X Garg; Richard Gilbert; Heather Harris; Rebecca Harvey; Brenda Hemmelgarn; Matthew James; Jeffrey Johnson; Joanne Kappel; Paul Komenda; Michael McCormick; Christopher McIntyre; Farid Mahmud; York Pei; Graham Pollock; Heather Reich; Norman D Rosenblum; James Scholey; Etienne Sochett; Mila Tang; Navdeep Tangri; Marcello Tonelli; Catherine Turner; Michael Walsh; Cathy Woods; Braden Manns Journal: Can J Kidney Health Dis Date: 2018-01-17
Authors: Laura A M Cummings; Antoine Clarke; Etienne Sochett; Denis Daneman; David Z Cherney; Heather N Reich; James W Scholey; David B Dunger; Farid H Mahmud Journal: J Pediatr Date: 2018-05-08 Impact factor: 4.406